{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:56:41Z","timestamp":1781539001421,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11095-026-04078-4","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:12:00Z","timestamp":1774307520000},"page":"1631-1643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Dual-Isotope Imaging Technique for Simultaneous Quantification and Evaluation of Biodistribution of Antibodies Using \u201cXCam-CdTe\u201d"],"prefix":"10.1007","volume":"43","author":[{"given":"Miho","family":"Nagayasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Katsuragawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Higashikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yagishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"7","key":"4078_CR1","first-page":"1224","volume":"45","author":"MJ Koppe","year":"2004","unstructured":"Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJ, et al. Biodistribution and therapeutic efficacy of (125\/131)I-, (186)Re-, (88\/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. J Nucl Med. 2004;45(7):1224\u201332.","journal-title":"J Nucl Med"},{"issue":"1","key":"4078_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1. https:\/\/doi.org\/10.1186\/s12929-019-0592-z.","journal-title":"J Biomed Sci"},{"issue":"1","key":"4078_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00100-4","volume":"3","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang G, Lu H, Li H, Tang M, Tong A. Development of therapeutic antibodies for the treatment of diseases. Mol Biomed. 2022;3(1):35. https:\/\/doi.org\/10.1186\/s43556-022-00100-4.","journal-title":"Mol Biomed"},{"issue":"3","key":"4078_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd.2017.227","volume":"17","author":"PJ Carter","year":"2018","unstructured":"Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the \u201chigh-hanging fruit.\u201d Nat Rev Drug Discov. 2018;17(3):197\u2013223. https:\/\/doi.org\/10.1038\/nrd.2017.227.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"4078_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108542","volume":"33","author":"F Mimoto","year":"2020","unstructured":"Mimoto F, Tatsumi K, Shimizu S, Kadono S, Haraya K, Nagayasu M, et al. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 2020;33(12):108542. https:\/\/doi.org\/10.1016\/j.celrep.2020.108542.","journal-title":"Cell Rep"},{"issue":"7","key":"4078_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s11095-023-03541-w","volume":"40","author":"M Nagayasu","year":"2023","unstructured":"Nagayasu M, Takano Y, Ozeki K. Development of a new method to evaluate the biodistribution of antibodies using non-radioactive metal labeling and inductively coupled plasma mass spectrometry. Pharm Res. 2023;40(7):1807\u201319. https:\/\/doi.org\/10.1007\/s11095-023-03541-w.","journal-title":"Pharm Res"},{"key":"4078_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081639","author":"S Kalimuthu","year":"2017","unstructured":"Kalimuthu S, Jeong JH, Oh JM, Ahn BC. Drug discovery by molecular imaging and monitoring therapy response in lymphoma. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18081639.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4078_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1359-6446(03)03018-6","volume":"9","author":"AE Nassar","year":"2004","unstructured":"Nassar AE, Talaat RE. Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Discov Today. 2004;9(7):317\u201327. https:\/\/doi.org\/10.1016\/S1359-6446(03)03018-6.","journal-title":"Drug Discov Today"},{"issue":"18","key":"4078_CR9","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.18632\/oncotarget.3968","volume":"6","author":"YH Shih","year":"2015","unstructured":"Shih YH, Peng CL, Lee SY, Chiang PF, Yao CJ, Lin WJ, et al. 111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma. Oncotarget. 2015;6(18):16601\u201310. https:\/\/doi.org\/10.18632\/oncotarget.3968.","journal-title":"Oncotarget"},{"issue":"1","key":"4078_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08951-1","volume":"12","author":"C Kaneko","year":"2022","unstructured":"Kaneko C, Tsutsui H, Ozeki K, Honda M, Haraya K, Narita Y, et al. In vivo imaging with two-photon microscopy to assess the tumor-selective binding of an anti-CD137 switch antibody. Sci Rep. 2022;12(1):4907. https:\/\/doi.org\/10.1038\/s41598-022-08951-1.","journal-title":"Sci Rep"},{"issue":"1","key":"4078_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01648-7","volume":"20","author":"A Refaat","year":"2022","unstructured":"Refaat A, Yap ML, Pietersz G, Walsh APG, Zeller J, Del Rosal B, et al. In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications. J Nanobiotechnology. 2022;20(1):450. https:\/\/doi.org\/10.1186\/s12951-022-01648-7.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4078_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.xphs.2020.05.025","volume":"110","author":"HP Chang","year":"2021","unstructured":"Chang HP, Kim SJ, Shah DK. Whole-body pharmacokinetics of antibody in mice determined using enzyme-linked immunosorbent assay and derivation of tissue interstitial concentrations. J Pharm Sci. 2021;110(1):446\u201357. https:\/\/doi.org\/10.1016\/j.xphs.2020.05.025.","journal-title":"J Pharm Sci"},{"issue":"1","key":"4078_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00216-022-04396-7","volume":"415","author":"P Legrand","year":"2023","unstructured":"Legrand P, Dufay S, Mignet N, Houze P, Gahoual R. Modeling study of long-term stability of the monoclonal antibody infliximab and biosimilars using liquid-chromatography-tandem mass spectrometry and size-exclusion chromatography-multi-angle light scattering. Anal Bioanal Chem. 2023;415(1):179\u201392. https:\/\/doi.org\/10.1007\/s00216-022-04396-7.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"4078_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4989","volume":"59","author":"A Mrsa","year":"2024","unstructured":"Mrsa A, Nardini G, Halvorsen TG, Thiede B, Reubsaet L. One-step functionalization of paper and simplified antibody immobilization for on-the-spot immunocapture from dried serum in liquid chromatography-tandem mass spectrometry based targeted protein determination. J Mass Spectrom. 2024;59(1):e4989. https:\/\/doi.org\/10.1002\/jms.4989.","journal-title":"J Mass Spectrom"},{"key":"4078_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095023","author":"G Crisan","year":"2022","unstructured":"Crisan G, Moldovean-Cioroianu NS, Timaru DG, Andries G, Cainap C, Chis V. Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23095023.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4078_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1053\/j.semnuclmed.2022.01.004","volume":"52","author":"P Ritt","year":"2022","unstructured":"Ritt P. Recent developments in SPECT\/CT. Semin Nucl Med. 2022;52(3):276\u201385. https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.01.004.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"4078_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09137-5","volume":"12","author":"IH Chiu","year":"2022","unstructured":"Chiu IH, Takeda S, Kajino M, Shinohara A, Katsuragawa M, Nagasawa S, et al. Non-destructive 3D imaging method using muonic X-rays and a CdTe double-sided strip detector. Sci Rep. 2022;12(1):5261. https:\/\/doi.org\/10.1038\/s41598-022-09137-5.","journal-title":"Sci Rep"},{"issue":"8","key":"4078_CR18","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1002\/mp.17124","volume":"51","author":"M Katsuragawa","year":"2024","unstructured":"Katsuragawa M, Yagishita A, Takeda S, Minami T, Ohnuki K, Fujii H, et al. CdTe XG-Cam: a new high-resolution x-ray and gamma-ray camera for studies of the pharmacokinetics of radiopharmaceuticals in small animals. Med Phys. 2024;51(8):5308\u201320. https:\/\/doi.org\/10.1002\/mp.17124.","journal-title":"Med Phys"},{"key":"4078_CR19","doi-asserted-by":"publisher","unstructured":"Shinichiro Takeda TO, Atsushi Yagishita, Miho Katsuragawa, Goro Yabu, Ryota Tomaru, Fumiki Moriyama, Hirotaka Sugawara, Shin Watanabe, Hiroshi Mizuma, Yousuke Kanayama, Kazunobu Ohnuki, Hirofumi Fujii, Lars R. Furenlid, Tadayuki Takahashi. CdTe-DSD SPECT-I: An Ultrahigh-Resolution Multi-Isotope Tomographic Imager for Mice. IEEE Transactions on Radiation and Plasma Medical Sciences. 2023;7(8):860\u201370. https:\/\/doi.org\/10.1109\/TRPMS.2023.3291756.","DOI":"10.1109\/TRPMS.2023.3291756"},{"key":"4078_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11010025","author":"A Yagishita","year":"2023","unstructured":"Yagishita A, Katsuragawa M, Takeda S, Shirakami Y, Ooe K, Toyoshima A, et al. Development and utility of an imaging system for internal dosimetry of Astatine-211 in mice. Bioengineering (Basel). 2023. https:\/\/doi.org\/10.3390\/bioengineering11010025.","journal-title":"Bioengineering (Basel)"},{"issue":"5","key":"4078_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41551-022-00866-6","volume":"6","author":"A Yagishita","year":"2022","unstructured":"Yagishita A, Takeda S, Katsuragawa M, Kawamura T, Matsumura H, Orita T, et al. Simultaneous visualization of multiple radionuclides in vivo. Nat Biomed Eng. 2022;6(5):640\u20137. https:\/\/doi.org\/10.1038\/s41551-022-00866-6.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"4078_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46907-1","volume":"13","author":"A Yagishita","year":"2023","unstructured":"Yagishita A, Takeda S, Ohnuki K, Katsuragawa M, Sampetrean O, Fujii H, et al. Dual-radionuclide in vivo imaging of micro-metastasis and lymph tract with submillimetre resolution. Sci Rep. 2023;13(1):19464. https:\/\/doi.org\/10.1038\/s41598-023-46907-1.","journal-title":"Sci Rep"},{"issue":"4","key":"4078_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10928-019-09641-8","volume":"46","author":"HY Chang","year":"2019","unstructured":"Chang HY, Wu S, Meno-Tetang G, Shah DK. A translational platform PBPK model for antibody disposition in the brain. J Pharmacokinet Pharmacodyn. 2019;46(4):319\u201338. https:\/\/doi.org\/10.1007\/s10928-019-09641-8.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"4078_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","volume":"39","author":"DK Shah","year":"2012","unstructured":"Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2012;39(1):67\u201386. https:\/\/doi.org\/10.1007\/s10928-011-9232-2.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"4078_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10928-007-9065-1","volume":"34","author":"A Garg","year":"2007","unstructured":"Garg A, Balthasar JP. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn. 2007;34(5):687\u2013709. https:\/\/doi.org\/10.1007\/s10928-007-9065-1.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"4078_CR26","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00588-8","volume":"23","author":"Z Li","year":"2021","unstructured":"Li Z, Yu X, Li Y, Verma A, Chang HP, Shah DK. A two-pore physiologically based pharmacokinetic model to predict subcutaneously administered different-size antibody\/antibody fragments. AAPS J. 2021;23(3):62. https:\/\/doi.org\/10.1208\/s12248-021-00588-8.","journal-title":"AAPS J"},{"issue":"1","key":"4078_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-025-01207-9","volume":"15","author":"N Cho","year":"2025","unstructured":"Cho N, Ho J, Rosario GD, Yu SF, Ferl GZ, Boswell CA. Measurement of specific and nonspecific tissue uptake of antibodies in tumor by SPECT imaging and nonlinear compartmental modeling. EJNMMI Res. 2025;15(1):15. https:\/\/doi.org\/10.1186\/s13550-025-01207-9.","journal-title":"EJNMMI Res"},{"issue":"6","key":"4078_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/19420862.2017.1337619","volume":"9","author":"MJ Eigenmann","year":"2017","unstructured":"Eigenmann MJ, Fronton L, Grimm HP, Otteneder MB, Krippendorff BF. Quantification of IgG monoclonal antibody clearance in tissues. MAbs. 2017;9(6):1007\u201315. https:\/\/doi.org\/10.1080\/19420862.2017.1337619.","journal-title":"MAbs"},{"issue":"5","key":"4078_CR29","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4049\/jimmunol.147.5.1548","volume":"147","author":"R Chizzonite","year":"1991","unstructured":"Chizzonite R, Truitt T, Podlaski FJ, Wolitzky AG, Quinn PM, Nunes P, et al. IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. J Immunol. 1991;147(5):1548\u201356.","journal-title":"J Immunol"},{"key":"4078_CR30","unstructured":"Nihon Medi-Physics Co. L: Interview-form of indium-chloride (111In) for injection.\u00a02019. https:\/\/www.nmp.co.jp\/sites\/default\/files\/2024-03\/IF_In-Cl_240318.pdf. Accessed Aug 2024."},{"key":"4078_CR31","unstructured":"Revvity I: Technical Data Sheet of Na125I, Product No. NEZ033A.\u00a02024.\u00a0https:\/\/resources.revvity.com\/pdfs\/NEZ033A_I120623A.pdf. Accessed Aug 2024."},{"key":"4078_CR32","volume-title":"Applied pharmacokinetics: theory and experiments","author":"M Hanano","year":"1985","unstructured":"Hanano M. Applied pharmacokinetics: theory and experiments. Tokyo: Soft Science; 1985."},{"key":"4078_CR33","volume-title":"Experimental animals; handling and experimental techniques","author":"M Okugi","year":"1976","unstructured":"Okugi M. Experimental animals; handling and experimental techniques. Tokyo: Nanzan do; 1976."},{"issue":"10","key":"4078_CR34","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jps.2600721003","volume":"72","author":"LE Gerlowski","year":"1983","unstructured":"Gerlowski LE, Jain RK. Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci. 1983;72(10):1103\u201327. https:\/\/doi.org\/10.1002\/jps.2600721003.","journal-title":"J Pharm Sci"},{"issue":"4","key":"4078_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11095-021-03028-6","volume":"38","author":"M Nagayasu","year":"2021","unstructured":"Nagayasu M, Ozeki K. Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice. Pharm Res. 2021;38(4):583\u201392. https:\/\/doi.org\/10.1007\/s11095-021-03028-6.","journal-title":"Pharm Res"},{"issue":"5","key":"4078_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1248\/bpb.b19-01042","volume":"43","author":"G Nakamura","year":"2020","unstructured":"Nakamura G, Ozeki K, Nagayasu M, Nambu T, Nemoto T, Hosoya KI. Predicting method for the human plasma concentration-time profile of a monoclonal antibody from the half-life of non-human primates. Biol Pharm Bull. 2020;43(5):823\u201330. https:\/\/doi.org\/10.1248\/bpb.b19-01042.","journal-title":"Biol Pharm Bull"},{"key":"4078_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000400","author":"T Kurino","year":"2020","unstructured":"Kurino T, Matsuda R, Terui A, Suzuki H, Kokubo T, Uehara T, et al. Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1\/PD-L1 blockade-sensitive mouse models. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000400.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"4078_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.nucmedbio.2016.03.007","volume":"43","author":"L Karmani","year":"2016","unstructured":"Karmani L, Leveque P, Bouzin C, Bol A, Dieu M, Walrand S, et al. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT\/CT imaging: impact of in vivo deiodination on tumor accumulation in mice. Nucl Med Biol. 2016;43(7):415\u201323. https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.03.007.","journal-title":"Nucl Med Biol"},{"issue":"7","key":"4078_CR39","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s11095-013-1286-y","volume":"31","author":"AP Joyce","year":"2014","unstructured":"Joyce AP, Wang M, Lawrence-Henderson R, Filliettaz C, Leung SS, Xu X, et al. One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeutics. Pharm Res. 2014;31(7):1823\u201333. https:\/\/doi.org\/10.1007\/s11095-013-1286-y.","journal-title":"Pharm Res"},{"issue":"7-8","key":"4078_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.drudis.2007.10.014","volume":"13","author":"B Liu","year":"2008","unstructured":"Liu B, Chang J, Gordon WP, Isbell J, Zhou Y, Tuntland T. Snapshot PK: a rapid rodent in vivo preclinical screening approach. Drug Discov Today. 2008;13(7\u20138):360\u20137. https:\/\/doi.org\/10.1016\/j.drudis.2007.10.014.","journal-title":"Drug Discov Today"},{"key":"4078_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14131431","author":"Y Bouchareb","year":"2024","unstructured":"Bouchareb Y, AlSaadi A, Zabah J, Jain A, Al-Jabri A, Phiri P, et al. Technological advances in SPECT and SPECT\/CT imaging. Diagnostics. 2024. https:\/\/doi.org\/10.3390\/diagnostics14131431.","journal-title":"Diagnostics"},{"issue":"1","key":"4078_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2214\/ajr.177.1.1770031","volume":"177","author":"JS Keppler","year":"2001","unstructured":"Keppler JS, Conti PS. A cost analysis of positron emission tomography. AJR Am J Roentgenol. 2001;177(1):31\u201340. https:\/\/doi.org\/10.2214\/ajr.177.1.1770031.","journal-title":"AJR Am J Roentgenol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04078-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:50Z","timestamp":1781537450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4078"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04078-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.N., K.H., K.O., and K.T. are full-time employees of Chugai Pharmaceutical, a member of the Roche Group, and M.N., K.H., K.O., and K.T. own shares in Chugai Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}